Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.75 -0.05 (-0.66%)
As of: Sep 10, 2026 · 9:55 AM EDT

Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings' (DNA) quarterly Non-Current Assets came in at $657.5 million in Q2 2026, down 7.13% on a YoY basis from $708.0 million in Q2 2025, and up 5.52% quarter-over-quarter from $623.1 million in Q1 2026.

Analysis

Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Non-Current Assets for 7 consecutive years, with $657.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets fell 7.13% year-over-year to $657.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.6 billion (down 13.81% YoY), and the FY2025 full-year result was $647.9 million, down 16.37% from the prior year.
  • Non-Current Assets advanced to $657.5 million in Q2 2026 per DNA's latest filing, from $623.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2023 and bottomed at $351.9 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $728.6 million across 5 years, with a median of $695.5 million in 2025.
  • The widest YoY moves for Non-Current Assets: up 213.05% in 2022, down 79.6% in 2022.
  • Over 5 years, Non-Current Assets stood at $1.1 billion in 2022, then slumped by 39.08% to $663.6 million in 2023, then rose by 16.74% to $774.7 million in 2024, then declined by 16.37% to $647.9 million in 2025, then increased by 1.49% to $657.5 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $657.5 million, $623.1 million, and $647.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Iqvia Holdings 42.22 Bn 40.14 Bn 1.44 Bn 23.66 Bn
2 Medpace Holdings 16.45 Bn 15.95 Bn 201.64 Mn 1.01 Bn
3 Charles River Laboratories International 13.14 Bn 12.95 Bn 452.07 Mn 6.00 Bn
4 Icon 12.38 Bn 11.45 Bn 479.29 Mn 12.65 Bn
5 Fortrea Holdings 1.57 Bn 1.40 Bn 139.20 Mn 1.79 Bn
6 Evotec SE 621.88 Mn 196.00 Mn - 982.30 Mn
7 Ginkgo Bioworks Holdings 418.69 Mn 334.15 Mn 18.44 Mn 657.51 Mn
8 Champions Oncology 71.79 Mn 71.79 Mn 7.03 Mn 7.77 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 3.76 Mn
10 VivoSim Labs 1.44 Mn 1.44 Mn - 621,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 657.51 Mn
Mar 31, 2026 623.12 Mn
Dec 31, 2025 647.86 Mn
Sep 30, 2025 683.08 Mn
Jun 30, 2025 707.98 Mn
Mar 31, 2025 728.93 Mn
Dec 31, 2024 774.71 Mn
Sep 30, 2024 818.40 Mn
Jun 30, 2024 841.89 Mn
Mar 31, 2024 678.74 Mn
Dec 31, 2023 663.59 Mn
Sep 30, 2023 884.55 Mn
Jun 30, 2023 1.07 Bn
Mar 31, 2023 1.09 Bn
Dec 31, 2022 1.09 Bn
Sep 30, 2022 408.69 Mn
Jun 30, 2022 395.37 Mn
Mar 31, 2022 351.89 Mn
Dec 31, 2021 347.95 Mn
Sep 30, 2021 340.02 Mn